Phyllis Barkman Ferrell , Global Head of External Engagement for Alzheimer’s disease & Neurodegeneration, Eli Lilly & CompanyTravis Bond , CEO,Altoida, Inc. Michael McFadden , CEO, Alpha Cognition, Inc.Lisa Ricciardi , CEO, Cognition Therapeutics, Inc.Brent Vaughan , CEO, Cognito Therapeutics
“We look forward to sharing our views and a lively discussion on this panel,” stated
The agenda is available on the Biotech Showcase website.
The event will be livestreamed and available for replay by registered attendees. Registration details may be found here: https://informaconnect.com/biotech-showcase/registration-options/.
About
Visit us at www.promisneurosciences.com, follow us on Twitter and LinkedIn
For Investor Relations please contact:
nick@alpineequityadv.com
Tel. 617 901-0785
The TSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. This information release contains certain forward-looking information. Such information involves known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by statements herein, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on the Company's current beliefs as well as assumptions made by and information currently available to it as well as other factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by the Company in its public securities filings, actual events may differ materially from current expectations. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
###
Source:
2022 GlobeNewswire, Inc., source